15-43776886-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000319359.8(ELL3):āc.16G>Cā(p.Glu6Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000103 in 1,611,206 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000319359.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ELL3 | NM_025165.3 | c.16G>C | p.Glu6Gln | missense_variant | 1/11 | ENST00000319359.8 | NP_079441.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ELL3 | ENST00000319359.8 | c.16G>C | p.Glu6Gln | missense_variant | 1/11 | 1 | NM_025165.3 | ENSP00000320346 | P1 | |
ELL3 | ENST00000433927.1 | c.106G>C | p.Glu36Gln | missense_variant | 2/6 | 5 | ENSP00000404209 | |||
ELL3 | ENST00000486851.5 | n.81G>C | non_coding_transcript_exon_variant | 1/5 | 2 | |||||
ELL3 | ENST00000497700.1 | n.83G>C | non_coding_transcript_exon_variant | 1/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000919 AC: 14AN: 152276Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000737 AC: 18AN: 244080Hom.: 0 AF XY: 0.0000678 AC XY: 9AN XY: 132826
GnomAD4 exome AF: 0.000104 AC: 152AN: 1458930Hom.: 0 Cov.: 33 AF XY: 0.000101 AC XY: 73AN XY: 725790
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152276Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74404
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2024 | The c.16G>C (p.E6Q) alteration is located in exon 1 (coding exon 1) of the ELL3 gene. This alteration results from a G to C substitution at nucleotide position 16, causing the glutamic acid (E) at amino acid position 6 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at